The Slovak government announced that it is temporarily discontinuing the use of AstraZeneca’s anticovid vaccine following the death of a 47-year-old woman from thrombosis who received that drug, although the second dose will continue to be given to those who have already received the first.
“The Ministry of Health is currently considering various alternatives on how Slovakia is going to face this situation,” said the spokeswoman for that institution, Zuzana Eliásová.
This death, the third registered in the Central European country after being administered a vaccine against covid, was announced last Friday and the authorities have reported that the woman suffered from a genetic defect that affected blood clotting.
The other two deceased had been immunized with the Moderna and Pfizer / Biontech preparations.
Those who have already received the first dose of AstraZeneca will also receive the second, despite this precautionary suspension.
Slovakia currently uses vaccines from Pfizer, Moderna and AstraZeneca, and is waiting to put the Russian Sputnik into circulation.
23% of the 5.45 million inhabitants of the country have already received a dose, while 11% are already fully immunized.
Slovakia, one of the countries affected in Europe during the second and third waves of the covid, registered a cumulative contagion rate in the last two weeks of 131 cases per 100,000 inhabitants, among the lowest on the continent.